Sapphire Medical Clinics
Medical Cannabis: Expert Opinion and Patient-Centred Treatment
Sapphire Medical Clinics provide doctors and patients with an expert opinion on their medical condition. Patients are seen by a consultant who specialises in their condition. We are here for clinicians who’ve yet to find an effective solution to challenging medical conditions, and for patients who’ve been referred to us to establish the next stage of treatment.
Why is Sapphire Unique?
Our team have been trained by international experts, we make the referral process safe and straightforward for doctors and put patients at the centre of all we do. There is a great deal of publicity around medicinal cannabis which understandably concerns many potential patients. At Sapphire, we have the reputation and the specialist knowledge to gain not just your trust, but that of your GP and other professionals involved in your care.
We are committed to providing safe, compassionate, effective and high-quality service standards therefore we have registered to be approved by the Care Quality Commission (CQC).
All of our prescribing clinicians have received specialist training in medicinal cannabis, as well as adhering to the formal prescribing guidelines by NHS England, MHRA and GMC.
Sapphire Medical invested in training and resources for GPs and relevant consultants in this new and uncharted treatment. Our work with international specialists who’ve prescribed medicinal cannabis to their patients for over 7 years gives us the up to date experience and knowledge of how to prescribe these products safely and effectively.
We pride ourselves on transparency and integrity. By partnering with Patients Know Best (PKB), an IT platform used by numerous NHS trusts, our patients have the autonomy to own their information and grant permission to the relevant professionals with speed and accuracy.
What legal changes have been made?
On 1st November 2018 the law in the UK was changed regarding medicinal cannabis. The change was to the Misuse of Drugs regulations 2001. Medicinal cannabis was re-scheduled from a schedule 1 drug (this means of no medical benefit) to a schedule 2 drug (this allows doctors to prescribe medicinal cannabis in certain situations).
In practice this means that some patients who have exhausted conventional therapies are able to receive a prescription for medicinal cannabis. Only doctors on the specialist register of the GMC are authorised to prescribe medicinal cannabis and satisfy the the guidelines issued by GMC, NHS England and MHRA.
We Are Seeking Approval
The General Medical Council (GMC) have very clear guidelines on prescribing unlicensed medications which we strictly adhere to, especially treating patients within our area of expertise and clinical specialty.
We have written our standard operating procedures to comply with the recommendations and guidelines of the GMC, MHRA and NHS England.
Sapphire Medical News & Current Developments
Reaction to Draft NICE Medical Cannabis Guidelines
Reaction to Draft NICE Medical Cannabis Guidelines Clinicians at Sapphire Medical Clinic, the UK’s first clinic offering consultations for all conditions believed
New guidelines published 8th August 2019
New guidelines published 8th August 2019 When medical cannabis was rescheduled last November the Secretary of State for Health and Social Care
Specialist Doctors Launch UK’s First Medicinal Cannabis Clinic To Treat Full Range of Health Issues
Specialist Doctors Launch UK’s First Medicinal Cannabis Clinic To Treat Full Range of Health Issues 23rd July 2019 A group of leading doctors have
Sapphire’s Principle Guidelines
Sapphire's Principle Guidelines 15th July 2019 Our principle guidelines are taken from NHS England, MHRA and GMC. You can find out more about these on